Mentoring the Next Generation

Max Wallace, CEO of Accelerate Brain Cancer Cure, mentors young researchers and budding biotech entrepreneurs at Duke University.

Last week, Max Wallace, CEO of ABC2, spoke with young student researchers and budding biotech entrepreneurs as part of the Fannie Mitchell Expert in Residence program at Duke University.  The program features accomplished professionals who share specialized knowledge and provide individual career advice to students. 

Max discussed the current state of biotech and the important role venture philanthropy organizations, such as ABC2, have in funding high-risk, high-reward research. "I can't think of a better way to ensure and promote the future of brain cancer research than to share our experiences with those who will lead us closer to a cure in the years to come," said Max.  "We're in the midst of a digital revolution in medicine and there are exciting opportunities for these bright young minds to help shape the future."

"Max gave an engaging presentation and was very well-received by undergraduate and graduate students alike," said Leslie Calihman Alabi, Program Coordinator at the Duke University Career Center.  "Many were inspired to stay after the group discussion to thank Max and to seek advice on developing themselves as pioneering researchers and change agents in science and medicine."

Share |
February 27, 2014 04:35 PM
ABC2's Max Wallace leads the NCI's Director's Consumer Liaison Group that addresses research issues critical to improving outcomes for patients with all types of cancers.
February 26, 2014 12:00 AM
The coalition includes Accelerate Brain Cancer Cure, the Musella Foundation for Brain Tumor Research and Information, the National Brain Tumor Society and the Society for Neuro-Oncology.
February 20, 2014 03:29 PM
An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM.  ABC2's petitioning of the FDA is noted.

Join us in our fight for a cure!

Twitter